Conference item icon

Conference item : Abstract

Filgotinib, a Janus kinase 1 (JAK1)-selective inhibitor, modulates disease associated cytokines in patients with active rheumatoid arthritis

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2019-eular.2510

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Oxford college:
St Peter's College
Role:
Author
ORCID:
0000-0001-7766-6167
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Journal:
European Congress of Rheumatology Annual Meeting - EULAR 2019 Journal website
Volume:
78
Issue:
S2
Pages:
736
Host title:
Annals of Rheumatic Diseases
Publication date:
2019-05-27
Acceptance date:
2019-03-29
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Source identifiers:
987872
Subtype:
Abstract
Pubs id:
pubs:987872
UUID:
uuid:aa6916d6-5846-4bc9-87ad-2c404e860445
Local pid:
pubs:987872
Deposit date:
2019-04-11

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP